Sign in
Enrolling by invitationNo phase

Neurobiology of Posttraumatic Stress Disorder Dysfunction and Recovery Following Cognitive Processing Therapy

Key facts

Who runs it
Milissa Kaufman
Where
Belmont, United StatesSee the site
Trial code
Status
Enrolling by invitation
People taking part
130 people, planned
Started
Mar 2016
Expected to end
Jun 2027
Type of study
Observational
Record updated
25 June 2026

Who can take part

Age
18 years to 55 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (13)Hide the full registry criteria

Who can take part

  • PTSD diagnosis, as measured by the Clinician Administered PTSD Scale for DSM-5
  • history of chronic childhood trauma due to relational abuse
  • Ability to understand and sign informed consent
  • Enrollment in CPT program at McLean Hospital
  • Both genders, all ethnic backgrounds, age between 18 and 55
  • Fluent English speakers
  • Normal or Corrected Vision

Who cannot take part

  • Metal implants
  • History or current schizophrenia spectrum disorder or other psychotic disorders
  • History or current bipolar or other related disorders
  • Alcohol and/or substance use disorder within the past month
  • Medical or neurological illness (e.g., seizures, head injury in which they experienced a loss of consciousness)
  • Positive pregnancy test

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Posttraumatic stress disorder

Where in United States

  • McLean HospitalBelmont, United StatesEnrolling by invitation

About the trial

What the trial wants to find out

Posttraumatic stress disorder (PTSD) is a significant personal and societal burden. The purpose of this study is to examine genetic, epigenetic, behavioral, and brain activity changes related to PTSD dysfunction and recovery before and after treatment with Cognitive Processing Therapy.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT02695953, who can take part
Record updated
25 June 2026